LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.
Nakata K, Ohuchida K, Nagai E, Hayashi A, Miyasaka Y, Kayashima T, Yu J, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M.
Nakata K, et al. Among authors: miyasaka y.
Neoplasia. 2009 Jul;11(7):712-9. doi: 10.1593/neo.09418.
Neoplasia. 2009.
PMID: 19568416
Free PMC article.